Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 50, 116462
Abstract
No abstract availableKeywords
Funding Information
- European Cooperation in Science and Technology (CA15135, CA18124, CA18133)
- Deutsche Forschungsgemeinschaft (GRK2158, INST208/664e1)
This publication has 44 references indexed in Scilit:
- Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligandsEuropean Journal of Pharmacology, 2011
- Combining Independent Drug Classes into Superior, Synergistically Acting Hybrid MoleculesAngewandte Chemie International Edition, 2010
- Discovery of a Class of Diketopiperazines as Antiprion CompoundsChemMedChem, 2010
- Amide bond formation: beyond the myth of coupling reagentsChemical Society Reviews, 2008
- Stereoselective Synthesis of 3,6-Disubstituted-3,6-dihydropyridin-2-ones as Potential Diketopiperazine Mimetics Using Organocopper-Mediated anti-SN2‘ Reactions and Their Use in the Preparation of Low-Molecule CXCR4 AntagonistsThe Journal of Organic Chemistry, 2006
- Improvements in Aldol Reactions with DiketopiperazinesSynthetic Communications, 2004
- Diketopiperazines in peptide and combinatorial chemistryJournal of Peptide Science, 2003
- Enantioselektive Synthese von α‐Methyl‐α‐amino‐carbonsäuren durch Alkylierung des Lactimethers von cyclo‐(L‐Ala‐L‐Ala)Angewandte Chemie, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Facile synthesis of methanesulfonate estersThe Journal of Organic Chemistry, 1970